Clinical requirements for calcium phosphate bone cements were formulated in terms of the initial setting time, the final setting time, the cohesion time, and the ultimate compressive strength. Two cement formulations were tested. Biocement F was made of a powder containing alpha-tertiary calcium pho
Calcium carbonate–calcium phosphate mixed cement compositions for bone reconstruction
✍ Scribed by C. Combes; R. Bareille; C. Rey
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 452 KB
- Volume
- 79A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The feasibility of making calcium carbonate–calcium phosphate (CaCO~3~–CaP) mixed cements, comprising at least 40% (w/w) CaCO~3~ in the dry powder ingredients, has been demonstrated. Several original cement compositions were obtained by mixing metastable crystalline CaCO~3~ phases with metastable amorphous or crystalline CaP powders in aqueous medium. The cements set within at most 1 h at 37°C in atmosphere saturated with water. The hardened cement is microporous and exhibits weak compressive strength. The setting reaction appeared to be essentially related to the formation of a highly carbonated nanocrystalline apatite phase by reaction of the metastable CaP phase with part or almost all of the metastable CaCO~3~ phase. The recrystallization of metastable CaP varieties led to a final cement consisting of a highly carbonated poorly crystalline apatite analogous to bone mineral associated with various amounts of vaterite and/or aragonite. The presence of controlled amounts of CaCO~3~ with a higher solubility than that of the apatite formed in the well‐developed CaP cements might be of interest to increase resorption rates in biomedical cement and favors its replacement by bone tissue. Cytotoxicity testing revealed excellent cytocompatibility of CaCO~3~–CaP mixed cement compositions. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
📜 SIMILAR VOLUMES
## Abstract A promising strategy to promote angiogenesis within an engineered tissue is the local and sustained delivery of an angiogenic factor by the substitute itself. Recently, we reported on functionalization of Biocement D (BioD) and several modifications of this calcium phosphate bone cement
## Abstract Calcium phosphate cement (CPC) that can be injected to form a scaffold in situ has promise for the repair of bone defects. However, its low‐strength limits the CPC to non‐stress‐bearing repairs. Fibrin glue (FG) with good sticking property and biocompatibility is possible used to reinfo
## Abstract Human leukocytes (peripheral blood mononuclear cells, PBMC) were overlaid on calcium phosphate bone cement (CBC, Norian SRS®) and allowed to settle for 1 h under cell culture conditions. Subsequently, the cells were either left unstimulated (i.e. sham stimulation using cell culture medi
## Abstract Injecting acrylic and, increasingly, calcium‐phosphate cements into the porous bone structure is an emerging procedure, referred to as vertebroplasty, for the augmentation of osteoporotic vertebrae. Despite the benefits of vertebroplasty, it has limitations. The limitations of interest
## Abstract Calcium phosphate cements (CPC), based on multicomponent powder mixtures of calcium orthophosphates with medium particle sizes in the region of 1 ‐ 20 μm, set isothermally in an aqueous environment to form hydroxyapatite (HA). HA cement reactants include tetracalcium phosphate (TTCP), t